GT Biopharma Inc expected to post a loss of 10 cents a share - Earnings Preview

GT Biopharma

27/10/2023 12:10

* GT Biopharma Inc  GTBP.OQ   GTBP.O  is expected to show no
change in quarterly revenue when it reports  results 
    * 
    * ​Refinitiv's mean analyst estimate for GT Biopharma Inc is
for a
loss of 10 cents per share. 
    * The one available analyst rating on the shares is "buy".  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for GT
Biopharma Inc
is $5​, above​ its last closing price of $0.25. ​​​

This summary was machine generated October 27 at 11:10 GMT.  All
figures in US dollars  unless otherwise stated